Stocks and Investing
Stocks and Investing
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (UHS) at Hold with Increased Target to $130 on, Mar 1st, 2023
Ben Hendrix of RBC Capital, Maintained "Universal Health Services, Inc." (UHS) at Hold with Increased Target from $114 to $130 on, Mar 1st, 2023.
Ben has made no other calls on UHS in the last 4 months.
There are 8 other peers that have a rating on UHS. Out of the 8 peers that are also analyzing UHS, 3 agree with Ben's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Fischbeck of "B of A Securities" Maintained at Hold and Held Target at $160 on, Tuesday, February 28th, 2023
- Andrew Mok of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $167 on, Tuesday, January 24th, 2023
- Stephen Baxter of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $154 on, Tuesday, January 3rd, 2023
These are the ratings of the 5 analyists that currently disagree with Ben
- Pito Chickering of "Deutsche Bank" Maintained at Strong Buy and Held Target at $160 on, Saturday, February 25th, 2023
- Steve Valiquette of "Barclays" Maintained at Sell with Increased Target to $132 on, Monday, January 9th, 2023
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $144 on, Wednesday, December 14th, 2022
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $157 on, Friday, November 25th, 2022
- Jamie Perse of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $121 on, Tuesday, November 1st, 2022
Contributing Sources